help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2005-0016
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/12/3023    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallejo, G.
Right arrow Articles by Saragüeta, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallejo, G.
Right arrow Articles by Saragüeta, P.
Molecular Endocrinology 19 (12): 3023-3037
Copyright © 2005 by The Endocrine Society

Progestin Activation of Nongenomic Pathways via Cross Talk of Progesterone Receptor with Estrogen Receptor ß Induces Proliferation of Endometrial Stromal Cells

Griselda Vallejo1, Cecilia Ballaré1, José Lino Barañao, Miguel Beato and Patricia Saragüeta

Instituto de Biología y Medicina Experimental (G.V., J.L.B., P.S.), Consejo Nacional de Investigaciones Científicas y Técnicas and Departamento de Química Biológica (J.L.B., P.S.), Facultad de Ciencias Exactas y Naturales Universidad de Buenos Aires, 1428 Buenos Aires, Argentina; and Centre de Regulació Genòmica (G.V., C.B., M.B.), Universitat Pompeu Fabra, 08003 Barcelona, Spain

Address all correspondence and requests for reprints to: Patricia Saragüeta, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Obligado 2490, (1428) Buenos Aires, Argentina. E-mail: sarag{at}dna.uba.ar.

Uterine decidualization is characterized by stromal cell proliferation and differentiation, which are controlled by ovarian hormones estradiol and progesterone. Here we report that the proliferative response of UIII rat uterine stromal cells to a short treatment with progestins requires active progesterone receptor (PR) and estrogen receptor ß (ERß) as well as a rapid and transient activation of Erk1–2 and Akt signaling. The optimal R5020 concentration for the proliferative response as well as for activation of the signaling cascades was between 10 and 100 pM. UIII cells are negative for ER{alpha} and have low levels of ERß and PR located mainly in the cytoplasm. Upon progestin treatment PR translocated to the cell nucleus where it colocalized with activated Erk1–2. Neither progestins nor estradiol transactivated the corresponding transfected reporter genes, suggesting that endogenous PR and ERß are transcriptionally incompetent. A fraction of endogenous PR and ERß form a complex as demonstrated by coimmunoprecipitation. Taken together, our results suggest that the proliferative response of uterine stromal cells to picomolar concentrations of progestins does not require direct transcriptional effects and is mediated by activation of the Erk1–2 and Akt signaling pathways via cross talk between PR and ERß.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  ERβ  |  PR
Ligands:   17β-Estradiol  |  RU486  |  R5020



This article has been cited by other articles:


Home page
J ANIM SCIHome page
F. Stormshak and C. V. Bishop
BOARD-INVITED REVIEW: Estrogen and progesterone signaling: Genomic and nongenomic actions in domestic ruminants
J Anim Sci, February 1, 2008; 86(2): 299 - 315.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. M. McGowan, A. J. Russell, V. Boonyaratanakornkit, D. N. Saunders, G. M. Lehrbach, C. M. Sergio, E. A. Musgrove, D. P. Edwards, and R. L. Sutherland
Progestins Reinitiate Cell Cycle Progression in Antiestrogen-Arrested Breast Cancer Cells through the B-Isoform of Progesterone Receptor
Cancer Res., September 15, 2007; 67(18): 8942 - 8951.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. L. Butts, S. A. Shukair, K. M. Duncan, E. Bowers, C. Horn, E. Belyavskaya, L. Tonelli, and E. M. Sternberg
Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion
Int. Immunol., March 1, 2007; 19(3): 287 - 296.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
G. P VICENT, C. BALLARE, R. ZAURIN, P. SARAGUETA, and M. BEATO
Chromatin Remodeling and Control of Cell Proliferation by Progestins via Cross Talk of Progesterone Receptor with the Estrogen Receptors and Kinase Signaling Pathways
Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 59 - 72.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. MIGLIACCIO, G. CASTORIA, M. D. DOMENICO, A. CIOCIOLA, M. LOMBARDI, A. DE FALCO, M. NANAYAKKARA, D. BOTTERO, R. DE STASIO, L. VARRICCHIO, et al.
Crosstalk between EGFR and Extranuclear Steroid Receptors
Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 194 - 200.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society